Pharmafile Logo
Pharmafocus logo
Advanced Search

AZ’s Dr Yunxia Bi joins ISP

March 30, 2011
Manufacturing and Production appointment, manufacturing and production

ISP Pharmaceuticals has appointed Dr Yunxia (Vivian) Bi as technical director of its solubility initiative. It is a newly-created position …

Appointment
Erbitux (cetixumab)

Merck re-submits Erbitux to the EMA for lung cancer

March 30, 2011
Sales and Marketing EGFR, Erbitux, Iressa, Merck KGaA, NSCLC, Tarceva, lung cancer drugs, non-small cell lung cancer

Merck KGaA has re-submitted Erbitux’s lung cancer licence extension to the EMA after its first application to the regulator was …

News

Milburn adds his voice to growing disquiet on NHS reforms

March 30, 2011
Alan Milburn, NHS, NHS reforms

Former Labour health secretary Alan Milburn has come out against the government’s health reforms, adding to the chorus of voices …

News

NHS Alliance: Social enterprises are future of public health services

March 30, 2011
NHS, NHS Alliance, NHS reforms, Right to Request, public health services, social enterprise

The NHS Alliance has once more backed the idea that social enterprise should form the backbone of public health services …

News
Doctor patient

New pharma skills needed for GP commissioning changes

March 30, 2011
Business Services, Sales and Marketing NHS reforms, skills, training

With GP-led commissioning taking the NHS into new territory, market access is facing a major shake up. In January, one …

Feature

Dr Clive Deverson joins Photosound

March 30, 2011
Medical Communications appointment, medical communications

Photosound has appointed Dr Clive Deverson as head of client strategy and medical communications. He joins the Hertfordshire, UK-based global …

Appointment

EU Clinical Trials Register is Launched

March 29, 2011
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

The European Medicines Agency (EMA) has announced the launch of its EU Clinical Trials Register. This online register allows public …

News
Press release
Roche

Roche changes raise Novartis takeover question

March 29, 2011
Sales and Marketing Novartis, Roche, mergers and acquisitions

Roche could be vulnerable to a takeover from its Swiss rival Novartis after changes in its boardroom. The Roche family …

News

Chiltern Expands European Operations with a New Office in The Netherlands

March 29, 2011
Research and Development

Chiltern International Limited (Chiltern), a global clinical contract research organization (CRO) announced that it has opened a new office in …

News
Press release

FDA issues guidance on glass contamination

March 29, 2011
Manufacturing and Production FDA, GMP, glass contamination

The FDA has issued an advisory to pharmaceutical manufacturers on the topic of contamination with thin glass fragments – or …

News

Contract research news in brief

March 28, 2011
Manufacturing and Production Almac, Aptiv Solutions, Cosmic Discoveries, InhibOx, Quintiles

Contract research organisation Quintiles Transnational has pulled back from plans to seek $2.4 billion in financing, saying that conditions in …

News

Gerresheimer buys Vedat to get bigger in South America

March 28, 2011
Manufacturing and Production Brazil, Gerresheimer, packaging

Glass and plastics packaging specialist Gerresheimer has acquired Brazilian company Vedat in a major push into the South American pharmaceutical …

News

IDT Biologika expands investment in German manufacturing capacity

March 28, 2011
Manufacturing and Production Germany, IDT Biologika, vaccines

IDT Biologika has said it plans to invest around 85 million euros in new production facilities and equipment in Germany …

News

Setback on road to recovery for Genzyme’s Allston facility

March 28, 2011
Manufacturing and Production Genzyme

Genzyme has been forced to discard one lot of its Fabry disease treatment Fabrazyme (agalsidase beta) manufactured at its troubled …

News

Kantar Health Names Jim Needell Managing Director, UK

March 28, 2011

Kantar Health Names Jim Needell Managing Director, UKNEW YORK, March 28, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing …

News
Press release

Nycomed files short bowel syndrome treatment

March 28, 2011
Medical Communications Nycomed, Revestive, gastrointestinal

Specialist pharma company Nycomed has submitted a novel bowel disease treatment for assessment by European regulators. The Marketing Authorisation Application …

News

New melanoma drug approved by FDA

March 28, 2011
Sales and Marketing BMS, melanoma

Yervoy, Bristol Myers Squibb’s new treatment for advanced skin cancer has gained approval in the US. The drug is the …

News
Pfizer Real Danger medicine spam

Digital Pharma: Social media boost for Pfizer anti-counterfeits campaign

March 28, 2011
Medical Communications Digital Pharma blog, Pfizer, counterfeits

Pfizer UK is using social media to reinvigorate its Real Danger patient safety campaign. The next phase of the campaign, …

News

Telaprevir to be added to standard hep C therapy

March 27, 2011
Research and Development, Sales and Marketing hepatitis C, telaprevir

Telaprevir – currently being co-developed by Vertex, Johnson & Johnson and Mitsubishi Tanabe  – will become part of a standard …

News

GSK withdraws applications for Avodart

March 25, 2011
Research and Development Avodart, Cancer, GSK, bph, prostate cancer

GlaxoSmithKline has withdrawn all regulatory applications for Avodart to prevent prostate cancer after regulators raised doubts about its benefit/risk profile. …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026